Estimated total costs of treating benign prostatic hyperplasia in Sweden

Scandinavian Journal of Urology and Nephrology

Volumn 29, Issue 1, 1995, Pages 57-63

  Ahlstrand, Christer ^a   Carlsson, Per ^b   Jönsson, Bengt ^c  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c STOCKHOLM SCHOOL OF ECONOMICS   (Sweden)

Author keywords

Benign prostatic hyperplasia; Cost analysis

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY;

AMBULATORY CARE; COSTS AND COST ANALYSIS; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; PREVALENCE; PROSTATIC HYPERPLASIA; SUPPORT, NON-U.S. GOV'T; SWEDEN;

EID: 0028926530     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365599509180540     Document Type: Article

References (21)

1. The current concept of benign prostatic hyperplasia
2. Spridning och ekonomiska effekter av medicinsk teknologi- vid behandling av magsår, prostataförstoring och gallsten
3. Är det dags att införa snävare indikationer för transuretral prostataresektion?
4. Economic burden of treated benign prostatic hyperplasia in the United Kingdom
5. Urinary symptom and quality of life questions indicative of obstructive benign prostatic hyperplasia
6. High prevalence of benign prostatic hypertrophy in the community
7. American Urological Association survey of transurethral prostatectomy and the impact of changing Medicare reimbursement
8. Primärvård i privat entreprenad
9. Diagnosredovisning för läkarbesök vid vårdcentralen i Tierp